Vistagen Therapeutics, Inc.
VTGN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001411685
No open-market purchases or sales by Vistagen Therapeutics, Inc. insiders were filed in the last 90 days; 48 institutions reported holding it in 13F filings for Q2 2026, worth $2.54M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Vistagen Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Vistagen Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Williamson Douglas J | Director | – | Jul 31, 2026 | 1 |
| Adler Reid G. | Chief Legal Officer | 60,868 | Jul 2, 2026 | 2 |
| Tressler Nick B. | Chief Financial Officer | 11,712 | Jul 2, 2026 | 3 |
| Singh Shawn | President and CEO | 54,846 | Jul 2, 2026 | 2 |
| Angelov Angel S | Chief Medical Officer | – | May 19, 2026 | 1 |
| Prince Joshua S. | Chief Operating Officer | 15,249 | Apr 9, 2026 | 2 |
| Cote Elissa S. | Chief Corp Development Officer | – | Apr 9, 2026 | 1 |
| Edick Paul R | Director | – | Nov 4, 2025 | 1 |
| Saxe Jon S | Director | – | Sep 11, 2025 | 0 |
| Cunningham Ann Michelle | Director | – | Sep 11, 2025 | 0 |
| Curley Joanne | Director | – | Sep 11, 2025 | 0 |
| Rotunno Mary L. | Director | – | Sep 11, 2025 | 0 |
| FitzPatrick Margaret M | Director | – | Sep 11, 2025 | 0 |
| Anderson Cynthia Lynn | CHIEF FINANCIAL OFFICER | 12,801 | Jul 1, 2025 | 0 |
| Gin Jerry B | Director | 100,000Indirect | Sep 10, 2024 | 0 |
| Commodore Capital LP | 10% Owner | 1,575,000Indirect | Oct 6, 2023 | 0 |
| Dotson Jerrold Duane | VP, CFO | 3,671 | Jul 5, 2023 | 0 |
| Smith Mark Alan | CHIEF MEDICAL OFFICER | 19,915 | Jul 15, 2022 | 0 |
| VHCP Management II, LLC | 10% Owner | 20,637,286Indirect | Jul 14, 2022 | 0 |
| Venrock Healthcare Capital Partners II, L.P. | 10% Owner | 20,637,286Indirect | Jul 14, 2022 | 0 |
| Koh Bong Y | 10% Owner | 20,637,286Indirect | Jul 14, 2022 | 0 |
| VHCP Co-Investment Holdings II, LLC | 10% Owner | 20,637,286Indirect | Jul 14, 2022 | 0 |
| Shah Nimish P | 10% Owner | 20,637,286Indirect | Jul 14, 2022 | 0 |
| Venrock Healthcare Capital Partners III, L.P. | 10% Owner | 20,637,286Indirect | Jul 14, 2022 | 0 |
| VHCP Management III, LLC | 10% Owner | 20,637,286Indirect | Jul 14, 2022 | 0 |
| VHCP Co-Investment Holdings III, LLC | 10% Owner | 20,637,286Indirect | Jul 14, 2022 | 0 |
| Venrock Healthcare Capital Partners EG, L.P. | 10% Owner | 20,637,286Indirect | Jul 14, 2022 | 0 |
| VHCP Management EG, LLC | 10% Owner | 20,637,286Indirect | Jul 14, 2022 | 0 |
| Snodgrass H. Ralph | PRES./CHIEF SCIENTIFIC OFFICER | 64,958 | Jan 3, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 9, 2023 (view filing) | Aug 7 | 2 days | Commodore Capital LP10% Owner | PPurchase | +775.8K | $23.15 | +$18.0M | +97.1%1.57M after | |
| Aug 22, 2022 (view filing)5:12 PM ET | Aug 18 | 4 days | Gin Jerry BDirector | PPurchase | +100.0K | $0.1787 | +$17.9K | New position100.0K after | |
| Aug 22, 2022 (view filing)5:12 PM ET | Aug 18 | 4 days | Gin Jerry BDirector | PPurchase | +100.0K | $0.1787 | +$17.9K | New position100.0K after | |
| Aug 19, 2022 (view filing)3:45 PM ET | Aug 17 | 2 days | Adler Reid G.CHIEF LEGAL OFFICER | PPurchase | +300.0K | $0.1697 | +$50.9K | +866.3%334.6K after | |
| Aug 18, 2022 (view filing)3:56 PM ET | Aug 17 | 1 day | Singh ShawnCHIEF EXECUTIVE OFFICER | PPurchase | +600.0K | $0.172 | +$103.2K | +2,287.1%626.2K after | |
| Jul 14, 2022 (view filing)5:33 PM ET | Jul 12 | 2 days | VHCP Management II, LLC and 9 others10% Owner | SSale | −60.0K | $0.89 | −$53.4K | −0.3%20.6M after | |
| Sep 8, 2021 (view filing) | Sep 7 | 1 day | Dotson Jerrold DuaneVP, CFO AND SECRETARY | SSale | −30.0K | $3.13 | −$93.9K | −29.2%72.8K after | |
| Aug 18, 2021 (view filing) | Aug 17 | 1 day | Snodgrass H. RalphPRES./CHIEF SCIENTIFIC OFFICER | PPurchase | +3.75K | $2.73 | +$10.2K | +12.1%34.6K after |